Heparin-binding EGF-like growth factor is an early response gene to chemotherapy and contributes to chemotherapy resistance (Q40227623)

18 September 2017

Heparin-binding EGF-like growth factor is an early response gene to chemotherapy and contributes to chemotherapy resistance (English)

1 reference

18 September 2017

1 reference

F Wang

1

1 reference

18 September 2017

R Liu

2

1 reference

18 September 2017

S W Lee

3

1 reference

18 September 2017

C M Sloss

4

1 reference

18 September 2017

J Couget

5

1 reference

18 September 2017

J C Cusack

6

1 reference

18 September 2017

language of work or name

English

0 references

publication date

25 September 2006

1 reference

18 September 2017

1 reference

18 September 2017

26

1 reference

18 September 2017

14

1 reference

18 September 2017

2006-2016

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1209999

18 September 2017

0 references

cites work

Human trophoblast survival at low oxygen concentrations requires metalloproteinase-mediated shedding of heparin-binding EGF-like growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209999

Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209999

Targeting signal transduction pathways by chemopreventive agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209999

p53 induction of heparin-binding EGF-like growth factor counteracts p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209999

ADAM-mediated ectodomain shedding of HB-EGF in receptor cross-talk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209999

Identification of serum factor inducing ectodomain shedding of proHB-EGF and sStudies of noncleavable mutants of proHB-EGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209999

Expression of Heparin-Binding Epidermal Growth Factor-like Growth Factor in Pancreatic Adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209999

17beta-estradiol enhances heparin-binding epidermal growth factor-like growth factor production in human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209999

Gefitinib ("Iressa", ZD1839) inhibits SN38-triggered EGF signals and IL-8 production in gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209999

Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209999

Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209999

Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is a mediator of multiple physiological and pathological pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209999

HB-EGF is a potent inducer of tumor growth and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209999

Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209999

Possible chemoresistance-related genes for gastric cancer detected by cDNA microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209999

The stress- and inflammatory cytokine-induced ectodomain shedding of heparin-binding epidermal growth factor-like growth factor is mediated by p38 MAPK, distinct from the 12-O-tetradecanoylphorbol-13-acetate- and lysophosphatidic acid-induced signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209999

Wound-induced HB-EGF ectodomain shedding and EGFR activation in corneal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209999

Roles of eukaryotic ribosomal proteins in maturation and transport of pre-18S rRNA and ribosome function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209999

NF- kappa B and chemoresistance: potentiation of cancer drugs via inhibition of NF- kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209999

7 January 2021

AP-1 mediates stretch-induced expression of HB-EGF in bladder smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209999

7 January 2021

EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209999

7 January 2021

Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209999

7 January 2021

Effects of IKK inhibitor PS1145 on NF-kappaB function, proliferation, apoptosis and invasion activity in prostate carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209999

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209999

1 reference

Dimensions Publication ID

18 September 2017

0 references

1 reference